The latest updates from RDNZ and the rare disorder community. 

Jun 15, 2020, 7:10 PM
Report from ECRD and RDI virtual conferences

RDNZ’s Chief Executive Lisa Foster attended two major European conferences in May.

May 25, 2020, 5:30 PM
Fair for Rare NZ campaign update

Now that New Zealand is opening up after the COVID-19 lockdown, we are ready to re-ignite our collective call for fairness for people with rare disorders.

May 10, 2020, 9:28 PM
Media statement – PHARMAC’s funding increase

Rare Disorders NZ is extremely disappointed with the announcement yesterday of a pre-budget boost to PHARMAC’s funding by $160 million over four years.

Apr 29, 2020, 1:52 PM
MSD makes temporary changes as part of COVID-19 response

The Ministry of Social Development (MSD) has made some temporary changes to document requirements as part of the COVID-19 response.

Apr 22, 2020, 7:18 PM
Media statement: Recent PHARMAC funding decisions

You may have read about PHARMAC’S decision this week to scrap a lung cancer drug funding plan.

Apr 16, 2020, 3:53 PM
CE update - together we are strong

Here at Rare Disorders NZ we have been busy asking, listening and providing a voice to the Government to ensure the needs of people with rare disorders are included in their planning.

Apr 15, 2020, 4:30 PM
Media release: Rare Disorders NZ provides vital voice for vulnerable group

RDNZ commends the Government for ensuring there is a way for the rare disorder community’s concerns to be heard and needs to be met.

Apr 6, 2020, 6:01 PM
Resilience webinar for the rare disorder community

RDNZ hosted a short live webinar with Tracey Hancock, a Life Coach who has herself navigated through health challenges and faced her own fears.

Apr 5, 2020, 1:42 PM
Ministry of Social Development update

Update from the Ministry of Social Development of support available during the COVID-19 crisis.

Mar 29, 2020, 4:57 PM
New website for carers

Our Carers Alliance partners, Carers NZ and IHC have launched a new website to make it easy to care for and about each other.